SPUTOLYSIN POWDER DIN 00698229
Status: Marketed
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: DEMBREXINE (DEMBREXINE HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | DEMBREXINE (DEMBREXINE HYDROCHLORIDE) 5 MG |
|---|---|
| Dosage form | Powder |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1987 |
| Current status date | 11-Feb-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25199 | 2021-02-11 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 5420 | 2004-09-22 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL MANUFACTURING SITE FOR THE MEDICINAL INGREDIENT |